✦ LIBER ✦

Results of Prolonged Follow-Up of Late-Onset Pompe Disease Treated with Alglucosidase Alfa (Myozyme®)

✍ Scribed by P. Laforêt; C. Payan; K. Laloui; J.-Y. Hogrel; C. Wary; R. Carlier; N. Pellegrini; A.-L. Bedat-Millet; I. Durieu; A. Furby; I. Penisson-Besnier; J. Praline; D. Orlikowski; N. Guffon-Fouilhoux; A. Levy; B. Eymard

Book ID: 113544411
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 86 KB
Volume: 33
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2011.05.074

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P4.50 Results of prolonged follow-up of

P4.50 Results of prolonged follow-up of late-onset Pompe disease treated with alglucosidase alfa (Myozyme)

✍ B. Eymard; C. Payan; K. Laloui; J.Y. Hogrel; C. Wary; R. Carlier; N. Pellegrini; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

69 Case report of patient with infantile

69 Case report of patient with infantile-onset Pompe disease treated with alglucosidase alfa beginning at age 16

✍ Judith Phalin; Berkley R. Powell; Susan C. Winter 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Rate of disease progression during long-

Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease

✍ N.A.M.E. Van der Beek; M.L.C. Hagemans; A.J.J. Reuser; W.C.J. Hop; A.T. Van der 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 231 KB

M.P.2.06 Gradual disease progression dur

M.P.2.06 Gradual disease progression during long-term follow up of patients with late-onset Pompe disease

✍ N. Van der Beek; M. Hagemans; A. Reuser; W. Hop; A. van der Ploeg; P. Van Doorn; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Enzyme replacement therapy with alglucos

Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial

✍ S. Strothotte; N. Strigl-Pill; B. Grunert; C. Kornblum; K. Eger; C. Wessig; M. D 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 244 KB

A novel mutation of the GAA gene in a Fi

A novel mutation of the GAA gene in a Finnish late-onset pompe disease patient: Clinical phenotype and follow-up with enzyme replacement therapy

✍ Mari P. Korpela; Anders Paetau; Mervi I. Löfberg; Marjut H. Timonen; Antti E. La 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

## Abstract Pompe disease is a rare, progressive disease leading to skeletal muscle weakness due to deficiency of the acid α‐glucosidase (GAA) enzyme. Herein we report the first diagnosed Finnish patient with a phenotype compatible with the late‐onset form of Pompe disease. Molecular genetic analys